Kovai Medical Center & Hospital shareholders have approved the re-designation of Dr. Arun N Palaniswami from Executive Director to Joint Managing Director. The special resolution passed via postal ballot with overwhelming support, securing 96.03% of valid votes cast.

The approval covers the re-designation for the remaining period of his current tenure, effective August 7, 2026. It also includes the remuneration payable to him from that date. The voting process concluded on September 19, 2026, with results declared on September 21, 2026.

Voting Breakdown

The postal ballot was conducted through remote e-voting facilities provided by National Securities Depository Limited (NSDL). A total of 177 ballot forms were received, representing 67,88,472 shares. After excluding two invalid votes, 175 valid votes were counted.

Only 20,027 shareholders were eligible to vote as of the cut-off date of August 14, 2026. The low number of dissenting votes indicates broad consensus among investors regarding the leadership transition.

Regulatory Compliance

The process adhered to Regulation 44(3) of the SEBI (LODR) Regulations 2015 and Sections 108 and 110 of the Companies Act, 2013. M D Selvaraj, FCS, of MDS & Associates LLP, served as the independent scrutinizer. He certified that the voting was conducted fairly and transparently, confirming the requisite majority was achieved.

What the Numbers Show

The high participation rate relative to the small shareholder base (177 votes from ~20,000 eligible members) suggests concentrated ownership or high engagement among active holders. The near-unanimous assent (96.03%) underscores strong confidence in Dr. Palaniswami’s continued leadership role within the organization.

Kovai Medical Center and Hospital Limited shareholders approved all four agenda items at its 40th Annual General Meeting held on August 26, 2026. The resolutions, including the adoption of FY26 financials and dividend declaration, received overwhelming support from the promoter group and public institutions.

The virtual meeting commenced at 11:00 am and concluded at 12:21 pm via Video Conferencing / Other Audio-Visual Means (VC/OAVM). Sixty-four members attended the session, chaired by Managing Director Dr. Nalla G Palaniswami. The scrutinizer report, submitted by K. Duraisami, confirmed that remote e-voting ran from August 23 to August 25, 2026.

Voting Results Overview

A total of 107 members holding 67,05,898 shares participated in remote e-voting. Of these, nine promoter group members holding 61,64,883 shares cast their votes. Public non-institutional participation was lower, with 98 members holding 5,41,016 shares voting. One member voted during the AGM itself.

Key Resolutions

Shareholders approved the adoption of annual financial statements for the fiscal year ended March 31, 2026, as an ordinary resolution. The declaration of dividend for FY26 also passed as an ordinary resolution. Additionally, the company secured approval for the appointment of Dr. M.C. Thirumoorthi as a director liable to retire by rotation through a special resolution. The ratification of remuneration payable to the cost auditor was approved as an ordinary resolution.

Governance and Compliance

Statutory auditors M/s VKS Aiyer & Co. submitted their report for the year ended March 31, 2026, with no adverse remarks. Mr. K. Duraisami served as the scrutinizer for the e-voting process. The votes were unblocked on August 26, 2026, at 12:40 pm in the presence of two independent witnesses.

The promoter group, holding 61,84,883 shares, voted in favor of all resolutions. Public institutions holding 4,56,256 shares also supported all items. Among public non-institutions holding 43,01,123 shares, dissenting votes were recorded only for the appointment of Dr. M.C. Thirumoorthi, with 69 votes against.